Prognostic nomogram for hepatocellular carcinoma patients after transarterial chemoembolization based on des-γ-carboxy prothrombin reactivity and modified Response Evaluation Criteria in Solid Tumors

Solid Tumors ◽

Evaluation Criteria ◽

Response Evaluation ◽

Comparison of α-Fetoprotein Criteria and Modified Response Evaluation Criteria in Solid Tumors for the Prediction of Overall Survival of Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2018.07.031 ◽

2018 ◽

Vol 29 (12) ◽

pp. 1654-1661 ◽

Cited By ~ 7

Author(s):

Ying-Qiang Zhang ◽

Li-Juan Jiang ◽

Jia Wen ◽

Di-Min Liu ◽

Gui-Hua Huang ◽

...

Keyword(s):

Overall Survival ◽

Solid Tumors ◽

Evaluation Criteria ◽

Response Evaluation ◽

Appropriateness and limitations of modified Response Evaluation Criteria in Solid Tumors (mRECIST) in evaluating the efficacy of molecular-targeted therapy for patients with hepatocellular carcinoma

Kanzo ◽

10.2957/kanzo.53.147 ◽

2012 ◽

Vol 53 (3) ◽

pp. 147-154 ◽

Cited By ~ 2

Author(s):

Haruhiko Takeda ◽

Yukio Osaki ◽

Tadashi Inuzuka ◽

Jun Nakajima ◽

Fumihiro Matsuda ◽

...

Keyword(s):

Targeted Therapy ◽

Solid Tumors ◽

Molecular Targeted Therapy ◽

Evaluation Criteria ◽

Response Evaluation ◽

Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

The Oncologist ◽

10.1634/theoncologist.2013-0114 ◽

2014 ◽

Vol 19 (4) ◽

pp. 394-402 ◽

Cited By ~ 78

Author(s):

Maxime Ronot ◽

Mohamed Bouattour ◽

Johanna Wassermann ◽

Onorina Bruno ◽

Chantal Dreyer ◽

...

Keyword(s):

Solid Tumors ◽

European Association ◽

Evaluation Criteria ◽

Response Criteria ◽

Advanced Hepatocellular Carcinoma ◽

Response Evaluation ◽

Alternative Response ◽

Recist 1.1 ◽

Use of Initial Modified RECIST Tumor Response Evaluation Criteria for Predicting Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization with Drug-Eluting Beads

Journal of Cancer Therapy ◽

10.4236/jct.2015.613121 ◽

2015 ◽

Vol 06 (13) ◽

pp. 1115-1123

Author(s):

Natália Sousa Freitas Queiroz ◽

Luciana Kikuchi ◽

Regis Otaviano Franca Bezerra ◽

Regiane S. S. M. Alencar ◽

Aline Lopes Chagas ◽

...

Keyword(s):

Tumor Response ◽

Evaluation Criteria ◽

Response Evaluation ◽

Tumor Response Evaluation ◽

Drug Eluting Beads ◽

Drug Eluting ◽

Modified Recist ◽

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602

Upsala Journal of Medical Sciences ◽

10.3109/03009734.2012.729104 ◽

2012 ◽

Vol 118 (1) ◽

pp. 16-22 ◽

Cited By ~ 32

Author(s):

Yozo Sato ◽

Hirokazu Watanabe ◽

Miyuki Sone ◽

Hiroaki Onaya ◽

Noriaki Sakamoto ◽

...

Keyword(s):

Solid Tumors ◽

Tumor Response ◽

Transcatheter Arterial Chemoembolization ◽

Evaluation Criteria ◽

Response Evaluation ◽

Tumor Response Evaluation ◽

Modified Recist ◽

Response Evaluation Criteria ◽

Arterial Chemoembolization

Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

Cancer ◽

10.1002/cncr.26255 ◽

2011 ◽

Vol 118 (1) ◽

pp. 147-156 ◽

Cited By ~ 178

Author(s):

Julien Edeline ◽

Eveline Boucher ◽

Yan Rolland ◽

Elodie Vauléon ◽

Marc Pracht ◽

...

Keyword(s):

Solid Tumors ◽

Tumor Response ◽

Evaluation Criteria ◽

Response Evaluation ◽

Modified Recist ◽

Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma

BMC Research Notes ◽

10.1186/s13104-015-1565-2 ◽

2015 ◽

Vol 8 (1) ◽

Cited By ~ 12

Author(s):

Juichi Takada ◽

Hisashi Hidaka ◽

Takahide Nakazawa ◽

Masaaki Kondo ◽

Kazushi Numata ◽

...

Keyword(s):

Solid Tumors ◽

Evaluation Criteria ◽

Advanced Hepatocellular Carcinoma ◽

Response Evaluation ◽

Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib

JGH Open ◽

10.1002/jgh3.12420 ◽

2020 ◽

Vol 4 (6) ◽

pp. 1183-1190

Author(s):

Shun Kaneko ◽

Kaoru Tsuchiya ◽

Yutaka Yasui ◽

Kento Inada ◽

Sakura Kirino ◽

...

Keyword(s):

Solid Tumors ◽

Evaluation Criteria ◽

Response Evaluation ◽

Radiological Response ◽

Abstract No. 27: Do the RECIST Amendment for Tumor Response Evaluation criteria correlate better with patient outcomes than the RECIST 1.1 criteria after conventional transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)?

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2009.12.170 ◽

2010 ◽

Vol 21 (2) ◽

pp. S13

Author(s):

P. Kranokpiraksa ◽

J.R. Kachura ◽

R. Beecroft ◽

K. Tan ◽

D.K. Rajan ◽

...

Keyword(s):

Patient Outcomes ◽

Tumor Response ◽

Evaluation Criteria ◽

Response Evaluation ◽

Recist 1.1 ◽

Tumor Response Evaluation ◽

The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization

Gut and Liver ◽

10.5009/gnl19197 ◽

2020 ◽

Vol 14 (6) ◽

pp. 765-774 ◽

Cited By ~ 3

Author(s):

Jae Seung Lee ◽

Hong Jun Choi ◽

Beom Kyung Kim ◽

Jun Yong Park ◽

Do Young Kim ◽

...

Keyword(s):

Solid Tumors ◽

Evaluation Criteria ◽

Response Evaluation ◽

Transarterial Radioembolization ◽

Recist 1.1 ◽